MIRA

MIRA Pharmaceuticals, Inc. - Common Stock (MIRA)

About MIRA Pharmaceuticals, Inc. - Common Stock (MIRA)

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.

Details

Daily high

$1.08

Daily low

$0.98

Price at open

$1.01

52 Week High

$5.01

52 Week Low

$0.51

Market cap

17.5M

Dividend yield

0.00%

Volume

627,298

Avg. volume

3.1M

P/E ratio

-2.15

MIRA Pharmaceuticals, Inc. - Common Stock News